Rhythm Pharmaceuticals (RYTM) Current Leases (2019 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Current Leases of $676000.0 for Q1 2026, up 201.79% year-over-year from $224000.0 in Q1 2025, and up 4.0% quarter-over-quarter from $650000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Current Leases (2019 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Current Leases for 8 consecutive years, with $676000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 201.79% year-over-year to $676000.0; the TTM figure through Mar 2026 stood at $676000.0 (up 201.79% YoY), while the FY2025 annual figure was $650000.0, changed N/A from the prior year.
- Current Leases grew to $676000.0 in Q1 2026 per RYTM's latest filing, from $650000.0 in the prior quarter.
- Across five years, Current Leases topped out at $816000.0 in Q2 2024 and bottomed at $224000.0 in Q1 2025.
- Historically, Current Leases has averaged $657266.7 across 5 years, with a median of $676000.0 in 2026.
- Annual changes were most pronounced in 2025 — Current Leases tumbled 71.75% — and 2026, when it soared 201.79%.
- Rhythm Pharmaceuticals' Current Leases stood at $684000.0 in 2022, then gained by 12.57% to $770000.0 in 2023, then climbed by 5.97% to $816000.0 in 2024, then fell by 20.34% to $650000.0 in 2025, then advanced by 4.0% to $676000.0 in 2026.
- Business Quant data shows RYTM's Current Leases at $676000.0 in Q1 2026, $650000.0 in Q4 2025, and $624000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 703,000.00 |
| Mar 31, 2026 | 676,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 624,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Jun 30, 2024 | 816,000.00 |
| Mar 31, 2024 | 793,000.00 |
| Dec 31, 2023 | 770,000.00 |
| Sep 30, 2023 | 748,000.00 |
| Jun 30, 2023 | 726,000.00 |
| Mar 31, 2023 | 705,000.00 |
| Dec 31, 2022 | 684,000.00 |
| Sep 30, 2022 | 664,000.00 |
| Jun 30, 2022 | 644,000.00 |
| Mar 31, 2022 | 625,000.00 |
| Dec 31, 2021 | 606,000.00 |
| Sep 30, 2021 | 588,000.00 |
| Jun 30, 2021 | 570,000.00 |
| Mar 31, 2021 | 553,000.00 |